Ticker > Company >

Caplin Point Lab share price

Caplin Point Laboratories Ltd.

NSE: CAPLIPOINT BSE: 524742 SECTOR: Pharmaceuticals & Drugs  221k   1k   252

2143.50
+3.10 (0.14%)
BSE: 13 Jun 04:01 PM

Price Summary

Today's High

₹ 2147.15

Today's Low

₹ 2065.05

52 Week High

₹ 2636

52 Week Low

₹ 1369.75

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

16293.11 Cr.

Enterprise Value

16077.33 Cr.

No. of Shares

7.6 Cr.

P/E

47.99

P/B

9.58

Face Value

₹ 2

Div. Yield

0.14 %

Book Value (TTM)

₹  223.77

CASH

215.78 Cr.

DEBT

0 Cr.

Promoter Holding

70.56 %

EPS (TTM)

₹  44.66

Sales Growth

18.25%

ROE

22.69 %

ROCE

28.92%

Profit Growth

21.11 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year18.25%
3 Year9%
5 Year3.09%

Profit Growth

1 Year21.11%
3 Year22%
5 Year13.87%

ROE%

1 Year22.69%
3 Year22.77%
5 Year26.13%

ROCE %

1 Year28.92%
3 Year28.96%
5 Year33.37%

Debt/Equity

0

Price to Cash Flow

146.77

Interest Cover Ratio

3658.4

CFO/PAT (5 Yr. Avg.)

0.831101666165743

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2025 70.56 0.00
Dec 2024 70.56 0.00
Sep 2024 70.56 0.00
Jun 2024 70.56 0.00
Mar 2024 70.62 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 22.002876510717% for the Past 3 years.
  • Company has been maintaining healthy ROE of 22.7698637935884% over the past 3 years.
  • Company has been maintaining healthy ROCE of 28.9639962673565% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 3658.4.
  • The Company has been maintaining an effective average operating margins of 42.3237648871538% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of -29.1719 days.
  • Company has a healthy liquidity position with current ratio of 5.8935.
  • The company has a high promoter holding of 70.56%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 55.9001870103991.

 Limitations

  • The company has shown a poor revenue growth of 9.00022007207701% for the Past 3 years.
  • The company is trading at a high EV/EBITDA of 34.4111.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Net Sales 139.38 185.64 207.93 185.23 173.61
Total Expenditure 81.7 104.26 109.77 107.84 98.57
Operating Profit 57.68 81.38 98.16 77.39 75.04
Other Income 36.18 21.5 43.01 28.83 41.25
Interest 0.02 0.02 0.02 0.04 0.04
Depreciation 6.93 6.18 6.49 6.01 6.09
Exceptional Items 0 0 0 0 0
Profit Before Tax 86.91 96.68 134.66 100.17 110.16
Tax 17.03 24.14 28.92 25.46 23.66
Profit After Tax 69.88 72.54 105.74 74.71 86.5
Adjusted EPS (Rs) 9.2 9.54 13.91 9.83 11.38

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 527.83 482.68 528.06 528.61 625.09
Total Expenditure 320.83 273.14 308.58 309.23 338.01
Operating Profit 206.99 209.54 219.48 219.38 287.08
Other Income 65.97 23.01 56.69 99.54 105.84
Interest 0.19 0.17 0.09 0.12 0.1
Depreciation 19.65 22.44 25.77 25.65 27.08
Exceptional Items 0 0 0 0 0
Profit Before Tax 253.12 209.94 250.31 293.15 365.74
Tax 55.49 53.71 62.44 58.89 82.03
Net Profit 197.64 156.23 187.87 234.26 283.71
Adjusted EPS (Rs.) 26.13 20.65 24.79 30.86 37.35

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 15.13 15.13 15.16 15.18 15.19
Total Reserves 584.78 743.54 915.49 1124.73 1374.96
Borrowings 0.02 0 0 0 0
Other N/C liabilities 27.15 24.99 24.63 16.42 12.86
Current liabilities 64.26 77.33 98.88 146.85 119.3
Total Liabilities 691.33 860.99 1054.16 1303.18 1522.31
Assets
Net Block 166.93 182.68 162.46 156.85 165.79
Capital WIP 3.77 1.36 1.73 42.68 27.75
Intangible WIP 0 0 0.87 0 0
Investments 135.54 138.64 212.73 274.97 346.17
Loans & Advances 4.36 5.67 70.7 164.7 272.07
Other N/C Assets 0 20 0 2.28 7.43
Current Assets 380.74 512.64 605.67 661.7 703.1
Total Assets 691.33 860.99 1054.16 1303.18 1522.31
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 253.12 209.94 250.31 293.15 365.74
Adjustment -32.58 7.75 -19.43 -59.57 -68.57
Changes in Assets & Liabilities -83.19 131.85 62.07 -11.45 -99.07
Tax Paid -50.35 -54.9 -61.98 -65.03 -87.09
Operating Cash Flow 87.01 294.64 230.97 157.1 111.01
Investing Cash Flow -41 -3.9 -276.02 -85.67 -118.13
Financing Cash Flow -32.92 -3.47 -22.76 -30.42 -34.26
Net Cash Flow 13.09 287.27 -67.81 41.01 -41.38

Corporate Actions

Investors Details

PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
promoters 70.62 70.56 70.56 70.56 70.56
ashok gorkey partheeban 11.92 11.91 11.91 11.91 11.91
first dimension holdings ... 0.49 0.49 0.49 0.49 0.49
kiraviz properties and co... 0.20 0.20 0.20 0.20 0.20
may india property privat... 2.79 2.79 2.79 2.79 2.79
p vijayalakshmi 24.73 24.71 24.71 24.71 24.71
paarthipan c c 18.66 18.64 18.64 18.64 18.64
partheeban vivek siddarth... 11.85 11.84 11.84 11.84 11.84
PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
investors 29.38 29.44 29.44 29.44 29.44
investor education and pr... 2.72 2.72 2.71 2.76 2.74
llp 0.49 0.52 0.50 0.49 0.49
uti small cap fund - 1.21 1.47 1.39 1.27
foreign portfolio inv1&2 - - - 0.02 -
suresh kumar agarwal 1.32 1.32 - - -

Annual Reports

Title Action
Annual Report 2024
Annual Report 2023
Annual Report 2022
Annual Report 2021
Annual Report 2020
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY ACTION
No Credit reports exist for this company.Report us
TYPE AGENCY ACTION
Research HDFC Securities
Research HDFC Securities
Research HDFC Securities
Research Ventura

Concalls & Presentations

TYPE QUARTER ACTION
Concall Q4FY24
Concall Q3FY24
Concall Q3FY21
Concall Q3FY19
Concall Q2FY24
Concall Q2FY24
Concall Q2FY21
Concall Q1FY24
Concall Q1FY21
TYPE QUARTER ACTION
Presentation Q4FY24
Presentation Q4FY20
Presentation Q3FY24
Presentation Q3FY21
Presentation Q2FY24
Presentation Q2FY21
Presentation Q2FY20
Presentation Q1FY24
Presentation Q1FY21

Company News

Caplin Point Lab Stock Price Analysis and Quick Research Report. Is Caplin Point Lab an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Caplin Point Lab and its performance over the period of time. Caplin Point Lab stock price today is Rs 2140.3.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Caplin Point Lab cash from the operating activity was Rs 111.01 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Caplin Point Lab has a Debt to Equity ratio of 0 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Caplin Point Lab , the EPS growth was 21.0292 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Caplin Point Lab has OPM of 45.9261866291254 % which is a good sign for profitability.
     
  • ROE: Caplin Point Lab have a healthy ROE of 22.6925 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Caplin Point Lab is Rs 2140.3. One can use valuation calculators of ticker to know if Caplin Point Lab share price is undervalued or overvalued.
Last Updated on:
Brief about Caplin Point Lab
X